These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3383543)

  • 21. Pharmacokinetics of tobramycin in the camel.
    Hadi AA; Wasfi IA; Gadir FA; Amiri MH; Bashir AK; Baggot JD
    J Vet Pharmacol Ther; 1994 Feb; 17(1):48-51. PubMed ID: 8196094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accuracy of Bayesian, Sawchuk-Zaske, and nomogram dosing methods for vancomycin.
    Garrelts JC; Godley PJ; Horton MW; Karboski JA
    Clin Pharm; 1987 Oct; 6(10):795-9. PubMed ID: 3505841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous and subcutaneous pharmacokinetics of florfenicol in sheep.
    Lane VM; Villarroel A; Wetzlich SE; Clifford A; Taylor I; Craigmill AL
    J Vet Pharmacol Ther; 2004 Aug; 27(4):191-6. PubMed ID: 15305846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of vindesine given as an intravenous bolus and 24-hour infusion in humans.
    Ohnuma T; Norton L; Andrejczuk A; Holland JF
    Cancer Res; 1985 Jan; 45(1):464-9. PubMed ID: 3965152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of tobramycin pharmacokinetics after administration by CRIS and a traditional intravenous piggyback infusion.
    Mauro VF; Jacobs LR; Mauro LS; MacArthur RD; White DB
    Ann Pharmacother; 1995 May; 29(5):465-9. PubMed ID: 7655128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of two infusion methods for pharmacokinetic monitoring of gentamicin.
    Nahata MC; Crist KD
    Ther Drug Monit; 1990 Mar; 12(2):150-3. PubMed ID: 2315972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic studies on tobramycin in horses.
    Hubenov H; Bakalov D; Krastev S; Yanev S; Haritova A; Lashev L
    J Vet Pharmacol Ther; 2007 Aug; 30(4):353-7. PubMed ID: 17610409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic modelling of a once-daily dosing regimen for intravenous tobramycin in paediatric cystic fibrosis patients.
    Lam W; Tjon J; Seto W; Dekker A; Wong C; Atenafu E; Bitnun A; Waters V; Yau Y; Solomon M; Ratjen F
    J Antimicrob Chemother; 2007 Jun; 59(6):1135-40. PubMed ID: 17446242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bicompartmental kinetics of tobramycin analysed with a wide range of covariates.
    Inclan G; Suarez E; Calvo R; Aguirre C; Macheras P; Gazouli M; Lukas JC
    Int J Antimicrob Agents; 2005 Oct; 26(4):304-11. PubMed ID: 16168626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetics and EEG effects of midazolam during and after 1-minute, 1-hour, and 3-hour intravenous infusions.
    Greenblatt DJ; Ehrenberg BL; Culm KE; Scavone JM; Corbett KE; Friedman HL; Harmatz JS; Shader RI
    J Clin Pharmacol; 2004 Jun; 44(6):605-11. PubMed ID: 15145968
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Simultaneous analysis of the serum and urinary pharmacokinetics of fortimicin A after intravenous administration to healthy subjects.
    Sennello LT; Berman BI; Vance JF; Sonders RC
    Int J Clin Pharmacol Ther Toxicol; 1982 Sep; 20(9):393-8. PubMed ID: 7141758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacokinetic studies of tobramycin using the continuous intravenous infusion method (author's transl)].
    Yamasaku F; Yamada H
    Jpn J Antibiot; 1981 Nov; 34(11):1429-35. PubMed ID: 7334576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of serum aminoglycoside concentrations produced by two infusion methods.
    Bosch DE; Williams DN
    Clin Pharm; 1990 Oct; 9(10):777-80. PubMed ID: 2242658
    [No Abstract]   [Full Text] [Related]  

  • 34. Absolute bioavailability and absorption characteristics of aerosolized tobramycin in adults with cystic fibrosis.
    Cooney GF; Lum BL; Tomaselli M; Fiel SB
    J Clin Pharmacol; 1994 Mar; 34(3):255-9. PubMed ID: 8021334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of infusion method on serum tobramycin concentrations in adults with cystic fibrosis.
    Pleasants RA; Williams DM; Waltner WE; Knowles MR
    Clin Pharm; 1990 Jul; 9(7):541-5. PubMed ID: 2376111
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pharmacokinetic monitoring during aminoglycoside treatment: the optimal method for individualizing the dosage of tobramycin].
    Firsov AA; Manuĭlov KK; Fomina IP; Lukomskiĭ GI; Alekseeva ME
    Antibiot Khimioter; 1989 Dec; 34(12):915-20. PubMed ID: 2629652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of extracorporeal membrane oxygenation on tobramycin pharmacokinetics in sheep.
    Möller JC; Gilman JT; Kearns GL; Sussmane JB; Raszynski A; Wolfsdorf J; Reed MD
    Crit Care Med; 1992 Oct; 20(10):1454-8. PubMed ID: 1395668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single-dose pharmacokinetics of ampicillin and tobramycin administered by hypodermoclysis in young and older healthy volunteers.
    Champoux N; Du Souich P; Ravaoarinoro M; Phaneuf D; Latour J; Cusson JR
    Br J Clin Pharmacol; 1996 Sep; 42(3):325-31. PubMed ID: 8877023
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of various infusion pump administration techniques and rates on tobramycin delivery.
    Cacek AT; Moore JE; Bishop TS
    Am J Hosp Pharm; 1988 Nov; 45(11):2381-3. PubMed ID: 3228098
    [No Abstract]   [Full Text] [Related]  

  • 40. [Decrease in the concentration of tobramycin, vancomycin and phenobarbital in administration with infusion filter].
    Böhrer H; Zhang CH; Krier C
    Infusionstherapie; 1991 Apr; 18(2):96-100. PubMed ID: 1856006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.